COMMONWEALTH EQUITY SERVICES, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30
-50.0%
50,296
+9.7%
0.00%
Q2 2023$60
+27.7%
45,860
+70.1%
0.00%
Q1 2023$47
-43.4%
26,965
+1.5%
0.00%
Q4 2022$83
-99.9%
26,578
+11.6%
0.00%
Q3 2022$116,000
+18.4%
23,8240.0%0.00%
Q2 2022$98,000
-26.3%
23,824
+3.6%
0.00%
Q1 2022$133,000
-44.1%
23,006
-27.7%
0.00%
-100.0%
Q4 2021$238,000
-19.9%
31,820
-3.7%
0.00%0.0%
Q3 2021$297,000
-30.0%
33,038
-6.7%
0.00%0.0%
Q2 2021$424,000
-7.2%
35,429
-3.0%
0.00%0.0%
Q1 2021$457,000
+39.8%
36,529
+73.8%
0.00%0.0%
Q4 2020$327,000
+55.7%
21,015
-5.9%
0.00%0.0%
Q3 2020$210,000
+0.5%
22,327
-4.3%
0.00%0.0%
Q2 2020$209,000
+97.2%
23,327
+40.2%
0.00%
Q1 2020$106,000
-51.8%
16,640
-36.8%
0.00%
-100.0%
Q4 2019$220,000
+60.6%
26,312
+73.2%
0.00%0.0%
Q3 2019$137,000
-12.2%
15,193
+4.7%
0.00%0.0%
Q2 2019$156,000
+5.4%
14,515
-6.9%
0.00%0.0%
Q1 2019$148,000
-52.9%
15,596
-43.1%
0.00%
-50.0%
Q4 2018$314,000
-33.3%
27,420
-1.4%
0.00%0.0%
Q3 2018$471,000
+88.4%
27,818
+57.8%
0.00%
+100.0%
Q2 2018$250,000
-13.2%
17,633
+16.1%
0.00%
-50.0%
Q1 2018$288,00015,1860.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders